Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema

NCT05333055 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 107

Last updated 2025-01-24

No results posted yet for this study

Summary

The DRAGONS study is a non-interventional, prospective study that will

1. characterize disease state biomarker (including cytokines, KKS metabolites, and cell adhesion molecules) levels from aqueous humor of subjects with various stages of diabetic retinopathy (DR) and diabetic macular edema (DME) as well as other retinal pathologies, and
2. correlate a broad array of aqueous humor disease state biomarkers with DR severity, DME anti-vascular endothelial growth factor (VEGF) responsiveness, and other retinal pathologies.

Conditions

Sponsors & Collaborators

  • Greater Houston Retina Research

    lead OTHER

Principal Investigators

  • Charles C. Wykoff, MD, PhD · Greater Houston Retina Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2024-05-15
Completion
2024-05-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05333055 on ClinicalTrials.gov